| 今开：4.93 | 昨收：4.92 |
| 最高：5.1 | 最低：4.855 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.36921253E8 |
uniQure(QURE)05-07 20:05
$uniQure(QURE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-006916 Act: 34 Size: 323 KB 网页链接查看全文
uniQure(QURE)02-28 21:35
$uniQure(QURE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-001917 Act: 33 Size: 169 KB 网页链接查看全文
uniQure(QURE)02-29 05:45
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000191 Size: 5 KB 网页链接查看全文
uniQure(QURE)03-06 06:25
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000203 Size: 7 KB 网页链接查看全文
uniQure(QURE)04-12 19:05
$uniQure(QURE)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-004994 Act: 34 Size: 145 KB 网页链接查看全文
uniQure(QURE)02-28 21:05
$uniQure(QURE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-028484 Act: 34 Size: 328 KB 网页链接查看全文
uniQure(QURE)03-06 06:15
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000201 Size: 7 KB 网页链接查看全文
uniQure(QURE)05-02 04:35
$uniQure(QURE)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-006396 Act: 34 Size: 1 MB 网页链接查看全文
uniQure(QURE)04-24 19:05
$uniQure(QURE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005526 Act: 34 Size: 538 KB 网页链接查看全文
uniQure(QURE)02-27 05:35
$uniQure(QURE)$ 144 Report of proposed sale of securities Accession Number: 0001973379-24-000061 Act: 33 Size: 4 KB 网页链接查看全文
usbiostock2018-08-01 23:26
移除PGNX，更新$Sangamo Therapeutics, Inc.(SGMO)$ ，新增$Audentes Therapeutics, Inc.(BOLD)$ ，$uniQure N.V. - Ordinary Shares(QURE)$查看全文
usbiostock2018-07-10 06:21
近年来，基因治疗迅猛发展。今年年初，Science杂志发表综述《基因治疗时代的到来》（Gene therapy comes of age），越来越多的人意识到，基因治疗已成为目前的投资热点。今年5月，美国FDA宣布将加速某些基因治疗产品的审批，并特别指出，血友病将成为新政策最先支持的疾病。本文将讨论血友病的治疗...查看全文
usbiostock2018-06-28 19:53
$uniQure N.V. - Ordinary Shares(QURE)$ 公司宣布AMT-061治疗中重度血友病B型临床3期试验（HOPE-B研究）第一名患者开始接受治疗。公司还预计在7月份开始一项剂量确认的临床2b期试验，并在年底前公布一线数据。查看全文
淘沙见金2018-06-23 04:06
$Deciphera医药(DCPH)$ $QURE $uniQure N.V. - Ordinary Shares(QURE)$ $Zogenix, Inc. (ZGNX)$ 股价大跌难道是因为Russell Rebalancing ? FTSE Russell is rebalancing the large-cap Russell 1000 and the small-cap Russell 2000 indexes, which happens only once a year查看全文
蹊之美股生物医药2018-06-03 13:48
$uniQure N.V. - Ordinary Shares(QURE)$ $Voyager Therapeutics, Inc.(VYGR)$ $Spark Therapeutics, Inc. (ONCE)$查看全文
淘沙见金2018-05-07 21:48
As a result of this work, we are raising our assumed price for hemophilia gene therapies in our coverage universe to $1.5M per patient in the US ($1M in the EU), an increase from prior assumptions of $350,000-$500,000 (hemophilia A) and $500,000 (hemophilia B) per patient. ht...查看全文
小目标吖2018-02-15 10:33
超强（近期新高） $微博(WB)$ $uniQure N.V. - Ordinary Shares(QURE)$ $AnaptysBio, Inc.(ANAB)$查看全文
SomethingLikeThis2017-10-22 03:23
$uniQure N.V. - Ordinary Shares(QURE)$ 前四次做空都成立，但是最后一次仓位重失败了。事实上出现了一个三重头肩顶，但是现在看底部并没有破前低，在一分钟均线粘合处同时是十五分钟大趋势均线粘合处，现在看来应该再等趋势明确再进去。查看全文
淘沙见金2017-10-21 00:10
$uniQure N.V. - Ordinary Shares(QURE)$ 在宣布改用了跟$Spark Therapeutics, Inc.(ONCE)$ 类似的FIX-Padua基因之后股价大涨，对比几个做血友病的市值：SGMO $1.1 Billion. ONCE $2.9 Billion. QURE $480 million, 上升的空间不小啊查看全文
智通财经APP获悉，H.C. Wainwright分析师Patrick Trucchio重申uniQure(QURE.US)“买入”评级，并给予目标价90美元。在辉瑞公司(PFE.US)公布了基因疗法fidanacogene elaparvovec用于治疗中重度至重度B型血友病的3期BENEGENE-2试验的主要... 网页链接
$uniQure(QURE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-006914 Act: 34 Size: 6 MB 网页链接
$uniQure(QURE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-006916 Act: 34 Size: 323 KB 网页链接
$uniQure(QURE)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-006396 Act: 34 Size: 1 MB 网页链接
$uniQure(QURE)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005525 Act: 34 Size: 4 MB 网页链接
$uniQure(QURE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005526 Act: 34 Size: 538 KB 网页链接
$uniQure(QURE)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-004996 Act: 34 Size: 4 MB 网页链接
$uniQure(QURE)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-004994 Act: 34 Size: 145 KB 网页链接
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000203 Size: 7 KB 网页链接
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000199 Size: 7 KB 网页链接
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000201 Size: 7 KB 网页链接